Literature DB >> 15700153

Treosulfan and gemcitabine.

Ian A Cree, Michael H Neale, Uwe Reinhold, Christian M Kurbacher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15700153     DOI： 10.1007/s00432-004-0630-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  9 in total

Review 1.  Preclinical combination therapy with gemcitabine and mechanisms of resistance.

Authors:  G J Peters; V W Ruiz van Haperen; A M Bergman; G Veerman; E Smitskamp-Wilms; C J van Moorsel; C M Kuiper; B J Braakhuis
Journal:  Semin Oncol       Date:  1996-10       Impact factor: 4.929

2.  The ex vivo chemosensitivity profile of choroidal melanoma.

Authors:  N Myatt; I A Cree; C M Kurbacher; A J Foss; J L Hungerford; P N Plowman
Journal:  Anticancer Drugs       Date:  1997-09       Impact factor: 2.248

3.  Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study.

Authors:  Claudia Pföhler; Ian A Cree; Selma Ugurel; Christoph Kuwert; Nikolas Haass; Karsten Neuber; Ulrich Hengge; Pippa G Corrie; Markus Zutt; Wolfgang Tilgen; Uwe Reinhold
Journal:  Anticancer Drugs       Date:  2003-06       Impact factor: 2.248

Review 4.  Chemosensitivity testing as an aid to anti-cancer drug and regimen development.

Authors:  Ian A Cree
Journal:  Recent Results Cancer Res       Date:  2003

Review 5.  ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials.

Authors:  Christian M Kurbacher; Ottilia M Grecu; Ursula Stier; Tobias J Gilster; Margit-M Janát; Michael Untch; Gottfried Konecny; Howard W Bruckner; Ian A Cree
Journal:  Recent Results Cancer Res       Date:  2003

6.  Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma.

Authors:  P Terheyden; E B Bröcker; J C Becker
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

7.  Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside.

Authors:  M H Neale; N Myatt; I A Cree; C M Kurbacher; A J Foss; J L Hungerford; P N Plowman
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma.

Authors:  Sanjay Sharma; Michael H Neale; Federica Di Nicolantonio; Louise A Knight; Pauline A Whitehouse; Stuart J Mercer; Bernard R Higgins; Alan Lamont; Richard Osborne; Andrew C Hindley; Christian M Kurbacher; Ian A Cree
Journal:  BMC Cancer       Date:  2003-07-03       Impact factor: 4.430

9.  DNA alkylation and interstrand cross-linking by treosulfan.

Authors:  J A Hartley; C C O'Hare; J Baumgart
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.